Literature DB >> 34499581

MAGT1 is required for HeLa cell proliferation through regulating p21 expression, S-phase progress, and ERK/p38 MAPK MYC axis.

Caili Bi1,2,3, Xue Zhang1,4, Yueyue Chen1,2, Yushuo Dong1, Yixin Shi1, Yunshen Lei1, Dan Lv5, Xiaowei Cao1,6, Wei Li1,2, Hongcan Shi1,2.   

Abstract

Magnesium transporter subtype 1 (MAGT1) is known to participate in animal development and cell differentiation. Thus far, MAGT1 studies have mainly focused on its role in cardiomyocyte regulation and differentiation; only a few studies have demonstrated its role in cell proliferation. To investigate the underlying mechanism of MAGT1 in cell proliferation, HeLa and SiHa cells were transiently knocked down with different siRNAs. We showed that cell proliferation was substantially restricted by S-phase arrest and apoptosis in the MAGT1-knocked down cells, which was further confirmed by the increased expression of p21, cyclin-A1, and cyclin-B1, as well as the decreased expression of MYC, cyclin-D1, cyclin-E1, and CDK2. MAGT1 knockdown also resulted in significant changes in the transcriptional expression of 1,598 genes that were analyzed by RNA sequencing. Bioinformatics analysis showed that MAGT1 was related to the MAPK signaling pathway. Western blot analysis confirmed that the phosphorylation of extracellular signal-related protein kinase 1/2 (ERK1/2) and p38 was remarkably reduced in MAGT1 down-regulated groups. Additionally, MAGT1 was required for the function of viral proteins E6/E7 during cell proliferation and G1/S cell-cycle progression. Therefore, MAGT1 plays a crucial role in the proliferation of HPV-positive cervical cancer cells, S-phase progression, and the ERK/p38 MAPK signaling pathway. These results indicate the potential of MAGT1 as a novel target for anticancer research.Abbreviations: MAGT1: Magnesium transporter subtype 1; MAPK: Mitogen-activated protein kinase; XMEN: X-linked immunodeficiency with Magnesium defect, Epstein-Barr virus infection and Neoplasia; BMMSCs: Bone Marrow Mesenchymal Stem Cells; Dpp: Decapentaplegic; CDKIs: CDK inhibitors; GPCR: G-protein coupled receptor; GO: Gene Ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes; RTK: Receptor Tyrosine Kinase; PTK: Protein Tyrosine Kinase; FGFR: Fibroblast Growth Factor Receptor; BMP: Bone Morphogenetic Protein; HPV18 E6/E7: Human Papillomavirus 18 Early protein 6/ early protein 7; FACS: Fluorescence Activated Cell Sorting; PI: Propidium Iodide.

Entities:  

Keywords:  MAGT1; MAPK; MYC; S-phase arrest; p21

Mesh:

Substances:

Year:  2021        PMID: 34499581      PMCID: PMC8794507          DOI: 10.1080/15384101.2021.1974792

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   5.173


  41 in total

1.  Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis.

Authors:  M W Gramling; C M Eischen
Journal:  Cell Death Differ       Date:  2012-02-03       Impact factor: 15.828

Review 2.  Loss of MAGT1 abrogates the Mg2+ flux required for T cell signaling and leads to a novel human primary immunodeficiency.

Authors:  Feng-Yen Li; Michael J Lenardo; Benjamin Chaigne-Delalande
Journal:  Magnes Res       Date:  2011-09       Impact factor: 1.115

Review 3.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

4.  Cdc2-cyclin E complexes regulate the G1/S phase transition.

Authors:  Eiman Aleem; Hiroaki Kiyokawa; Philipp Kaldis
Journal:  Nat Cell Biol       Date:  2005-07-10       Impact factor: 28.824

Review 5.  The role of MAGT1 in genetic syndromes.

Authors:  Valentina Trapani; Naomi Shomer; Evica Rajcan-Separovic
Journal:  Magnes Res       Date:  2015-06       Impact factor: 1.115

6.  Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E.

Authors:  L G Martin; G W Demers; D A Galloway
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

Review 7.  Magnesium in man: implications for health and disease.

Authors:  Jeroen H F de Baaij; Joost G J Hoenderop; René J M Bindels
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

8.  Identification of a novel activity of human papillomavirus type 16 E6 protein in deregulating the G1/S transition.

Authors:  Ilaria Malanchi; Sandra Caldeira; Maja Krützfeldt; Marianna Giarre; Marianna Alunni-Fabbroni; Massimo Tommasino
Journal:  Oncogene       Date:  2002-08-22       Impact factor: 9.867

9.  Cyclin A is required for the onset of DNA replication in mammalian fibroblasts.

Authors:  F Girard; U Strausfeld; A Fernandez; N J Lamb
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

Review 10.  Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling.

Authors:  Christopher J Caunt; Stephen M Keyse
Journal:  FEBS J       Date:  2012-08-28       Impact factor: 5.542

View more
  3 in total

1.  Transcription factor KLF16 activates MAGT1 to regulate the tumorigenesis and progression of breast cancer.

Authors:  Lin Li; Xi Zhang; Yuqi Li; Bo Xiao; Sibiao Pei; Hangyu Jiang; Xiaofen Zhang
Journal:  Int J Mol Med       Date:  2022-07-07       Impact factor: 5.314

2.  Phycocyanin inhibits Helicobacter pylori-induced hyper-proliferation in AGS cells via activation of the ROS/MAPK signaling pathway.

Authors:  Yakun Bi; Daoyan Wu; Xiaojuan Wu; Fei Wang; Hang Yu; Pan Liu; Guzhen Cui; Zhenghong Chen
Journal:  Ann Transl Med       Date:  2022-02

Review 3.  Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer.

Authors:  Katie Joanna Miller; Mohammad Asim
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.